{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:54:29Z","timestamp":1783691669956,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["24-BR-02-03"],"award-info":[{"award-number":["24-BR-02-03"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2022-NR075084"],"award-info":[{"award-number":["RS-2022-NR075084"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00408736"],"award-info":[{"award-number":["RS-2024-00408736"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea Healthcare Technology R&D","award":["HI21C1795"],"award-info":[{"award-number":["HI21C1795"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-026-03811-5","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:25:23Z","timestamp":1776345923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic targeting of blood-derived protein infiltration to modulate neuroinflammation in cerebellar ataxia"],"prefix":"10.1186","volume":"23","author":[{"given":"Se Min","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Soon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunji","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi Beom","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Woon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee Euhn","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoungho","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hyuk","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Ryong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"3811_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8:359.","journal-title":"Signal Transduct Target Ther"},{"key":"3811_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41419-021-04404-1","volume":"12","author":"A Marcelo","year":"2021","unstructured":"Marcelo A, Afonso IT, Afonso-Reis R, Brito DVC, Costa RG, Rosa A, Alves-Cruzeiro J, Ferreira B, Henriques C, Nobre RJ, et al. Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy. Cell Death Dis. 2021;12:1117.","journal-title":"Cell Death Dis"},{"key":"3811_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/s13287-024-04020-8","volume":"15","author":"S Kim","year":"2024","unstructured":"Kim S, Sharma C, Hong J, Kim JH, Nam Y, Kim MS, Lee TY, Kim KS, Suk K, Lee HW, Kim SR. Post-symptomatic administration of hMSCs exerts therapeutic effects in SCA2 mice. Stem Cell Res Ther. 2024;15:411.","journal-title":"Stem Cell Res Ther"},{"key":"3811_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(09)70305-9","volume":"9","author":"T Klockgether","year":"2010","unstructured":"Klockgether T. Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurol. 2010;9:94\u2013104.","journal-title":"Lancet Neurol"},{"key":"3811_CR5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/mds.26158","volume":"30","author":"A Ramirez-Zamora","year":"2015","unstructured":"Ramirez-Zamora A, Zeigler W, Desai N, Biller J. Treatable causes of cerebellar ataxia. Mov Disord. 2015;30:614\u201323.","journal-title":"Mov Disord"},{"key":"3811_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.nic.2016.03.011","volume":"26","author":"A Rossi","year":"2016","unstructured":"Rossi A, Martinetti C, Morana G, Severino M, Tortora D. Neuroimaging of Infectious and Inflammatory Diseases of the Pediatric Cerebellum and Brainstem. Neuroimaging Clin N Am. 2016;26:471\u201387.","journal-title":"Neuroimaging Clin N Am"},{"key":"3811_CR7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/mds.29359","volume":"38","author":"Y Vazquez-Mojena","year":"2023","unstructured":"Vazquez-Mojena Y, Rodriguez-Cordova Y, Dominguez-Barrios Y, Leon-Arcia K, Miranda-Becerra D, Gonzalez-Zaldivar Y, Guerra-Bustillos G, Ziemann U, Auburger G, Rodriguez-Labrada R, et al. Peripheral Inflammation Links with the Severity of Clinical Phenotype in Spinocerebellar Ataxia 2. Mov Disord. 2023;38:880\u20135.","journal-title":"Mov Disord"},{"key":"3811_CR8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.2174\/011570159X379620250225075810","volume":"23","author":"C Tang","year":"2025","unstructured":"Tang C, Deng Q, Yuan X, Ding Z, Hu J, Peng L, Yuan H, Wan N, Gong Y, Ding S, et al. Peripheral Inflammation Profile of Cerebellar Ataxia. Curr Neuropharmacol. 2025.","journal-title":"Curr Neuropharmacol"},{"key":"3811_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-024-00557-1","volume":"21","author":"T Chen","year":"2024","unstructured":"Chen T, Dai Y, Hu C, Lin Z, Wang S, Yang J, et al. Cellular and molecular mechanisms of the blood-brain barrier dysfunction in neurodegenerative diseases. Fluids Barriers CNS. 2024;21:60.","journal-title":"Fluids Barriers CNS"},{"key":"3811_CR10","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.ajpath.2025.03.011","volume":"195","author":"MG Mayer","year":"2025","unstructured":"Mayer MG, Fischer T. Shared Mechanisms of Blood-Brain Barrier Dysfunction and Neuroinflammation in COVID-19 and Alzheimer\u2019s Disease. Am J Pathol. 2025.","journal-title":"Am J Pathol"},{"key":"3811_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101333","volume":"68","author":"MT Jeon","year":"2021","unstructured":"Jeon MT, Kim KS, Kim ES, Lee S, Kim J, Hoe HS, et al. Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease. Ageing Res Rev. 2021;68:101333.","journal-title":"Ageing Res Rev"},{"key":"3811_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s40478-020-00955-0","volume":"8","author":"D Duarte Lobo","year":"2020","unstructured":"Duarte Lobo D, Nobre RJ, Oliveira Miranda C, Pereira D, Castelhano J, Sereno J, Koeppen A, Castelo-Branco M, Pereira de Almeida L. The blood-brain barrier is disrupted in Machado-Joseph disease\/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples. Acta Neuropathol Commun. 2020;8:152.","journal-title":"Acta Neuropathol Commun"},{"key":"3811_CR13","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1523\/JNEUROSCI.23-13-05877.2003","volume":"23","author":"SH Choi","year":"2003","unstructured":"Choi SH, Joe EH, Kim SU, Jin BK. Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J Neurosci. 2003;23:5877\u201386.","journal-title":"J Neurosci"},{"key":"3811_CR14","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1038\/srep14764","volume":"5","author":"WH Shin","year":"2015","unstructured":"Shin WH, Jeon MT, Leem E, Won SY, Jeong KH, Park SJ, McLean C, Lee SJ, Jin BK, Jung UJ, Kim SR. Induction of microglial toll-like receptor 4 by prothrombin kringle-2: a potential pathogenic mechanism in Parkinson\u2019s disease. Sci Rep. 2015;5:14764.","journal-title":"Sci Rep"},{"key":"3811_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5607\/en.2016.25.4.147","volume":"25","author":"E Leem","year":"2016","unstructured":"Leem E, Jeong KH, Won SY, Shin WH, Kim SR. Prothrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic System. Exp Neurobiol. 2016;25:147\u201355.","journal-title":"Exp Neurobiol"},{"key":"3811_CR16","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/bph.15681","volume":"179","author":"S Kim","year":"2022","unstructured":"Kim S, Moon GJ, Kim HJ, Kim DG, Kim J, Nam Y, Sharma C, Leem E, Lee S, Kim KS, et al. Control of hippocampal prothrombin kringle-2 (pKr-2) expression reduces neurotoxic symptoms in five familial Alzheimer\u2019s disease mice. Br J Pharmacol. 2022;179:998\u20131016.","journal-title":"Br J Pharmacol"},{"key":"3811_CR17","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/biomedicines11051383","volume":"11","author":"S Kim","year":"2023","unstructured":"Kim S, Sharma C, Jung UJ, Kim SR. Pathophysiological Role of Microglial Activation Induced by Blood-Borne Proteins in Alzheimer\u2019s Disease. Biomedicines. 2023;11.","journal-title":"Biomedicines"},{"key":"3811_CR18","volume":"28","author":"S Kim","year":"2023","unstructured":"Kim S, Sharma C, Shin M, Kim HJ, Kim J, Kim SR. pKr-2 induces neurodegeneration via upregulation of microglial TLR4 in the hippocampus of AD brain. Brain Behav Immun. 2023;28:100593.","journal-title":"Brain Behav Immun"},{"key":"3811_CR19","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/cells12091222","volume":"12","author":"J Iannucci","year":"2023","unstructured":"Iannucci J, Grammas P. Thrombin, a Key Driver of Pathological Inflammation in the Brain. Cells. 2023;12.","journal-title":"Cells"},{"key":"3811_CR20","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/jnr.22318","volume":"88","author":"SR Kim","year":"2010","unstructured":"Kim SR, Chung ES, Bok E, Baik HH, Chung YC, Won SY, Joe E, Kim TH, Kim SS, Jin MY, et al. Prothrombin kringle-2 induces death of mesencephalic dopaminergic neurons in vivo and in vitro via microglial activation. J Neurosci Res. 2010;88:1537\u201348.","journal-title":"J Neurosci Res"},{"key":"3811_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-5-12","volume":"5","author":"X Chen","year":"2008","unstructured":"Chen X, Gawryluk JW, Wagener JF, Ghribi O, Geiger JD. Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer\u2019s disease. J Neuroinflammation. 2008;5:12.","journal-title":"J Neuroinflammation"},{"issue":"Suppl 1","key":"3811_CR22","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.3233\/JAD-2010-1376","volume":"20","author":"X Chen","year":"2010","unstructured":"Chen X, Ghribi O, Geiger JD. Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer\u2019s and Parkinson\u2019s diseases. J Alzheimers Dis. 2010;20(Suppl 1):S127\u2013141.","journal-title":"J Alzheimers Dis"},{"key":"3811_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5694\/j.1326-5377.2009.tb02453.x","volume":"190","author":"AK Verma","year":"2009","unstructured":"Verma AK, Brighton TA. The direct factor Xa inhibitor rivaroxaban. Med J Aust. 2009;190:379\u201383.","journal-title":"Med J Aust"},{"key":"3811_CR24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/ATVBAHA.110.202978","volume":"30","author":"E Perzborn","year":"2010","unstructured":"Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V. Rivaroxaban: a new oral factor Xa inhibitor. Arterioscler Thromb Vasc Biol. 2010;30:376\u201381.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3811_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nature26138","volume":"555","author":"DS Ghorpade","year":"2018","unstructured":"Ghorpade DS, Ozcan L, Zheng Z, Nicoloro SM, Shen Y, Chen E, Bluher M, Czech MP, Tabas I. Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. Nature. 2018;555:673\u20137.","journal-title":"Nature"},{"key":"3811_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/79162","volume":"26","author":"DP Huynh","year":"2000","unstructured":"Huynh DP, Figueroa K, Hoang N, Pulst SM. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet. 2000;26:44\u201350.","journal-title":"Nat Genet"},{"key":"3811_CR27","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18:e3000410.","journal-title":"PLoS Biol"},{"key":"3811_CR28","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/s41401-025-01504-y","volume":"46","author":"S Kim","year":"2025","unstructured":"Kim S, Park J, Eo H, Lee GB, Park SM, Shin M, Lee SE, Nam Y, Kim SR. Intracerebellar upregulation of Rheb(S16H) ameliorates motor dysfunction in mice with SCA2. Acta Pharmacol Sin. 2025.","journal-title":"Acta Pharmacol Sin"},{"key":"3811_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12974-022-02531-w","volume":"19","author":"C Zhao","year":"2022","unstructured":"Zhao C, Zhou T, Zhao X, Pang Y, Li W, Fan B, Li M, Liu X, Ma L, Zhang J, et al. Delayed administration of nafamostat mesylate inhibits thrombin-mediated blood-spinal cord barrier breakdown during acute spinal cord injury in rats. J Neuroinflammation. 2022;19:189.","journal-title":"J Neuroinflammation"},{"key":"3811_CR30","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2147\/JIR.S393850","volume":"16","author":"Y Lu","year":"2023","unstructured":"Lu Y, Li D, Huang Y, Sun Y, Zhou H, Ye F, Yang H, Xu T, Quan S, Pan J. Pretreatment with Eupatilin Attenuates Inflammation and Coagulation in Sepsis by Suppressing JAK2\/STAT3 Signaling Pathway. J Inflamm Res. 2023;16:1027\u201342.","journal-title":"J Inflamm Res"},{"key":"3811_CR31","doi-asserted-by":"publisher","first-page":"9768","DOI":"10.1038\/s41467-024-54049-9","volume":"15","author":"HE Mudrick","year":"2024","unstructured":"Mudrick HE, Lu SC, Bhandari J, Barry ME, Hemsath JR, Andres FGM, Ma OX, Barry MA, Reddy VS. Structure-derived insights from blood factors binding to the surfaces of different adenoviruses. Nat Commun. 2024;15:9768.","journal-title":"Nat Commun"},{"key":"3811_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.4103\/1673-5374.375345","volume":"19","author":"C Zhao","year":"2024","unstructured":"Zhao C, Zhou T, Li M, Liu J, Zhao X, Pang Y, Liu X, Zhang J, Ma L, Li W, et al. Argatroban promotes recovery of spinal cord injury by inhibiting the PAR1\/JAK2\/STAT3 signaling pathway. Neural Regen Res. 2024;19:434\u20139.","journal-title":"Neural Regen Res"},{"key":"3811_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019;5:24.","journal-title":"Nat Rev Dis Primers"},{"key":"3811_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature22044","volume":"544","author":"DR Scoles","year":"2017","unstructured":"Scoles DR, Meera P, Schneider MD, Paul S, Dansithong W, Figueroa KP, Hung G, Rigo F, Bennett CF, Otis TS, Pulst SM. Antisense oligonucleotide therapy for spinocerebellar ataxia type 2. Nature. 2017;544:362\u20136.","journal-title":"Nature"},{"key":"3811_CR35","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3389\/fimmu.2020.01588","volume":"11","author":"M Calvo-Rodriguez","year":"2020","unstructured":"Calvo-Rodriguez M, Garcia-Rodriguez C, Villalobos C, Nunez L. Role of Toll Like Receptor 4 in Alzheimer\u2019s Disease. Front Immunol. 2020;11:1588.","journal-title":"Front Immunol"},{"key":"3811_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1179\/1351000212Y.0000000005","volume":"17","author":"M Guevara-Garcia","year":"2012","unstructured":"Guevara-Garcia M, Gil-del Valle L, Velasquez-Perez L, Garcia-Rodriguez JC. Oxidative stress as a cofactor in spinocerebellar ataxia type 2. Redox Rep. 2012;17:84\u20139.","journal-title":"Redox Rep"},{"key":"3811_CR37","doi-asserted-by":"publisher","first-page":"e110024","DOI":"10.1371\/journal.pone.0110024","volume":"9","author":"Y Wang","year":"2014","unstructured":"Wang Y, Jin S, Sonobe Y, Cheng Y, Horiuchi H, Parajuli B, Kawanokuchi J, Mizuno T, Takeuchi H, Suzumura A. Interleukin-1beta induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes. PLoS ONE. 2014;9:e110024.","journal-title":"PLoS ONE"},{"key":"3811_CR38","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3390\/antiox13121462","volume":"13","author":"S Kim","year":"2024","unstructured":"Kim S, Jung UJ, Kim SR. Role of Oxidative Stress in Blood-Brain Barrier Disruption and Neurodegenerative Diseases. Antioxid (Basel). 2024;13.","journal-title":"Antioxidants (Basel)"},{"key":"3811_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/glia.20173","volume":"50","author":"V Waetzig","year":"2005","unstructured":"Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, Hanisch UK. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia. 2005;50:235\u201346.","journal-title":"Glia"},{"key":"3811_CR40","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.4049\/jimmunol.176.3.1869","volume":"176","author":"C Tsatsanis","year":"2006","unstructured":"Tsatsanis C, Androulidaki A, Alissafi T, Charalampopoulos I, Dermitzaki E, Roger T, Gravanis A, Margioris AN. Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1. J Immunol. 2006;176:1869\u201377.","journal-title":"J Immunol"},{"key":"3811_CR41","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3390\/nu17111925","volume":"17","author":"B Sharma","year":"2025","unstructured":"Sharma B, Agriantonis G, Dawson-Moroz S, Brown R, Simon W, Ebelle D, Chapelet J, Cardona A, Soni A, Siddiqui M et al. Caffeine: A Neuroprotectant and Neurotoxin in Traumatic Brain Injury (TBI). Nutrients. 2025;17.","journal-title":"Nutrients"},{"key":"3811_CR42","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/00498250500250493","volume":"35","author":"C Weinz","year":"2005","unstructured":"Weinz C, Buetehorn U, Daehler HP, Kohlsdorfer C, Pleiss U, Sandmann S, Schlemmer KH, Schwarz T, Steinke W. Pharmacokinetics of BAY 59-7939\u2013an oral, direct Factor Xa inhibitor\u2013in rats and dogs. Xenobiotica. 2005;35:891\u2013910.","journal-title":"Xenobiotica"},{"key":"3811_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","volume":"53","author":"W Mueck","year":"2014","unstructured":"Mueck W, Stampfuss J, Kubitza D, Becka M. Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban. Clin Pharmacokinet. 2014;53:1\u201316.","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03811-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03811-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03811-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T01:04:38Z","timestamp":1779843878000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03811-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3811"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03811-5","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human plasma samples were obtained from participants who provided written informed consent, following the Declaration of Helsinki. Experimental procedures involving human plasma were approved by the Institutional Review Board (IRB) of Kyungpook National University Chilgok Hospital (IRB approval numbers: 2019-02-008-002 and 2023-01-036-001). All procedures involving human participants were conducted in accordance with applicable ethical guidelines and institutional regulations. Detailed information regarding the human plasma samples is provided in Fig. S1.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain data from any individual person in any form (including details, images, or videos).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}